Combination studies of 40 and the CHK1 inhibitor PF-00477736 in brain, ovarian, colon,and prostate cancer cells confirmed synergism between WEE1 and CHK1,independent of p53 status.116. The gene discussed is CHEK1; the disease is prostate carcinoma.